MedPath

Effect of Darvyadi lauha in the management of Kamala with respect to Hepatocellular jaundice.

Phase 2
Conditions
Health Condition 1: R17- Unspecified jaundice
Registration Number
CTRI/2020/02/023545
Lead Sponsor
All India institute of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

a) Diagnosed by elevated bilirubin (Conjugated) in liver function test >1 mg/dl(17 micro mol/L)

b) Age :18-50

c) Sex ; either male or female

d) Greenish yellow discolouration of skin,sclera ,nails and buccal mucosa(haridra twak ,netra ,nakha,anana)

e) Reddish yellow faecal matter and urine(Rakta peeta sakrut mutra)

f) Burning sensation (Daha)

g) Indigestion(Avipaka)

h) Lethargy(Dourbalya)

i) Fatigue(Sadana)

j) Aruchi(Loss of taste)

Exclusion Criteria

1)Age below 18 years and above 50 years of either sex.

2)Pregnancy

3)Obstructive jaundice

4)Auto immune hepatitis

5)Hepatocellular Carcinoma

6)Liver Transplantation or Any other Condition Interfering with the result of the treatment.

7)Thalassemia major, Sickle cell Disease other haemolytic Jaundices

8)Ca -head of pancreas

9)Gilbertâ??s Syndrome

10)Patients having history of Chronic HTN&DM

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in elevated 1)Bilirubin along with L.F.T with changes in Clinical presentation .Timepoint: 0 day, 15th day, 30th day and follow up.
Secondary Outcome Measures
NameTimeMethod
Overall improvement in the quality of life.Timepoint: 30th day and follow up.
© Copyright 2025. All Rights Reserved by MedPath